Medien

Category: Nachrichten

Filtern nach
Gerd Grebing
29 August 2024

Besuchen Sie uns an unserem Stand S04, anlässlich der SSIEM 2024 in Porto, Portugal

Visit us at our Booth S04 at the SSIEM  from 03.09.2024-06.09.2024 in Porto, Portugal, we are looking forward to meet you there.
Gerd Grebing
7 November 2023

DIPHARMA SA BESTÄTIGT DIE ANERKENNUNG ALS EINES DER BESTEN UNTERNEHMEN DER SCHWEIZ

  Dipharma SA confirms the recognition as one of the best companies to work for in Switzerland Chiasso, Switzerland, November 6th, 2023 | Dipharma SA, a pharmaceutical company specialized in high quality and improved medicines for rare diseases, h...
Gerd Grebing
6 Oktober 2023

SAPROPTERIN DIHYDROCHLORID PULVER UND TABLETTEN SIND JETZT IN UK ERHÄLTLICH

Chiasso, Switzerland and Reading, England, October 4th, 2023 – Dipharma SA (“Dipharma”) and LogixX Pharma (“LogixX”) are delighted to announce the official launch of Sapropterin Dihydrochloride (“Sapropterin”) in the United Kingdom. Sapropterin Di...
Nachrichten
Gerd Grebing

Besuchen Sie uns an unserem Stand N11, anlässlich der SSIEM 2023 in Jersualem, Israel

Visit us at our booth N11 at the SSIEM  from 29.08.-01.09.2023  in Jerusalem, Israel, we are looking forward to meet you there.
Gerd Grebing
3 Juli 2023

SAPROPTERIN DIPHARMA IST JETZT IN EUROPA UND DER SCHWEIZ ERHÄLTLICH

SAPROPTERIN DIPHARMA IS NOW AVAILABLE IN EUROPE AND SWITZERLAND Chiasso, Switzerland, July 3rd, 2023 – – Dipharma SA (“Dipharma”) today announced that its product Sapropterin Dipharma is now available in main European Countries and in Switzerland....
Ursula Gerhards
27 Juni 2023

Dipharma und Logixx Pharma geben die Erteilung der Marktzulassung für generisches Sapropterin im Vereinigten Königreich bekannt

Chiasso, Switzerland and Reading, England, June 27, 2023 – Dipharma SA (“Dipharma”) and LogixX Pharma (“LogixX”) are pleased to announce that the Medicines and Healthcare Products Regulatory Agency (“MHRA”) has granted Marketing Authorization for ...
Ursula Gerhards
31 Mai 2023

Analog Pharma und Dipharma geben die Genehmigung der US FDA für einen abgekürzten Antrag auf ein neues Medikament (ANDA) für 20 mg generische Nitisinon-Kapseln (Temperaturstabil) bekannt.

Princeton, NJ and Chiasso, Switzerland, May 31st, 2023 | Analog Pharma (member of Duchesnay Pharmaceutical Group, hereafter “Analog”) and Dipharma S.A. (“Dipharma”) is pleased to announce that their 20 mg nitisinone abbreviated new drug applicatio...
Gerd Grebing
18 Oktober 2022

Dipharma SA wird als eines der besten Unternehmen der Schweiz für 2022 ausgezeichnet

Chiasso, September 15th, 2022 | Dipharma SA, a specialty pharmaceutical company specialized in high quality and improved medicines for rare diseases, has been recently recognized as one of the best places to work for in Switzerland. During the ass...
Gerd Grebing
10 Oktober 2022

Besuchen Sie unseren Stand im Rahmen der APS in Kassel

Visit us at our booth at the APS from 19.10.-21.10.2022 in Kassel, Germany, we are looking forward to meet you there.